CIK 0001625101 · Non-accelerated filer<br>Smaller reporting company
PULSE BIOSCIENCES, INC.
Sign in to watch- Ticker
- PLSE
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 465696597
- Phone
- 510-906-4600
- Business address
- 3957 POINT EDEN WAY, HAYWARD, CA, 94545
- Former names
- Electroblate, Inc.
- Open-market buys, last 90 days
- $199,937
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$199,937. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-18 | Danahy Kevin Patrick Chief Commercial Officer | Option exercise 10b5-1 | +5,000 | $1.53 | $8K | 48,298 |
| 2026-02-18 | Danahy Kevin Patrick Chief Commercial Officer | Sale 10b5-1 | −5,000 | $23.64 | $118K | 43,298 |
| 2026-02-18 | Danahy Kevin Patrick Chief Commercial Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −5,000 | 300,000 | ||
| 2026-02-17 | Danahy Kevin Patrick Chief Commercial Officer | Option exercise 10b5-1 | +20,000 | $1.53 | $31K | 63,298 |
| 2026-02-17 | Danahy Kevin Patrick Chief Commercial Officer | Sale 10b5-1 | −20,000 | $23.63 | $473K | 43,298 |
| 2026-02-17 | Danahy Kevin Patrick Chief Commercial Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −20,000 | 305,000 | ||
| 2026-02-13 | Danahy Kevin Patrick Chief Commercial Officer | Option exercise 10b5-1 | +20,000 | $1.53 | $31K | 63,298 |
| 2026-02-13 | Danahy Kevin Patrick Chief Commercial Officer | Sale 10b5-1 | −20,000 | $23.53 | $471K | 43,298 |
| 2026-02-13 | Danahy Kevin Patrick Chief Commercial Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −20,000 | 325,000 | ||
| 2026-02-12 | Danahy Kevin Patrick Chief Commercial Officer | Option exercise 10b5-1 | +20,000 | $1.53 | $31K | 63,298 |
| 2026-02-12 | Danahy Kevin Patrick Chief Commercial Officer | Sale 10b5-1 | −20,000 | $23.37 | $467K | 43,298 |
| 2026-02-12 | Danahy Kevin Patrick Chief Commercial Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −20,000 | 345,000 | ||
| 2026-02-11 | Danahy Kevin Patrick Chief Commercial Officer | Option exercise 10b5-1 | +20,000 | $1.53 | $31K | 63,298 |
| 2026-02-11 | Danahy Kevin Patrick Chief Commercial Officer | Sale 10b5-1 | −20,000 | $25.20 | $504K | 43,298 |
| 2026-02-11 | Danahy Kevin Patrick Chief Commercial Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −20,000 | 365,000 | ||
| 2026-02-10 | Danahy Kevin Patrick Chief Commercial Officer | Option exercise 10b5-1 | +20,000 | $1.53 | $31K | 63,298 |
| 2026-02-10 | Danahy Kevin Patrick Chief Commercial Officer | Sale 10b5-1 | −20,000 | $23.52 | $470K | 43,298 |
| 2026-02-10 | Danahy Kevin Patrick Chief Commercial Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −20,000 | 385,000 | ||
| 2026-02-09 | Danahy Kevin Patrick Chief Commercial Officer | Option exercise 10b5-1 | +20,000 | $1.53 | $31K | 63,298 |
| 2026-02-09 | Danahy Kevin Patrick Chief Commercial Officer | Sale 10b5-1 | −20,000 | $21.45 | $429K | 43,298 |
Page 2 of 15 · 292 trades